Main Management ETF Advisors, LLC Krystal Biotech, Inc. Transaction History
Main Management ETF Advisors, LLC
- $2.7 Billion
- Q3 2025
A detailed history of Main Management ETF Advisors, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 10,075 shares of KRYS stock, worth $2.08 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,075
Previous 5,047
99.62%
Holding current value
$2.08 Million
Previous $910,000
95.49%
% of portfolio
0.07%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
325Shares Held
25MCall Options Held
241KPut Options Held
625K-
Black Rock Inc. New York, NY3.95MShares$814 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$576 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.78MShares$573 Million6.7% of portfolio
-
State Street Corp Boston, MA1.4MShares$288 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.02MShares$210 Million10.94% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.29B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...